XML 24 R11.htm IDEA: XBRL DOCUMENT v3.10.0.1
Financial Instruments
12 Months Ended
Dec. 31, 2018
Investments, Debt and Equity Securities [Abstract]  
Financial Instruments
Financial Instruments
Cash Equivalents
The Company had $10 and $644 of held-to-maturity securities with original maturities of three months or less, primarily consisting of corporate debt securities, classified as cash equivalents at December 31, 2018 and 2017, respectively. The Company's investments in held-to-maturity securities were held at amortized cost, which approximates fair value.
Restricted Cash and Cash Equivalents
The Company had restricted cash and cash equivalents of $22 and $23 at December 31, 2018 and 2017, respectively. The Company's restricted cash and cash equivalents are primarily related to balances that are restricted for payment of distributions to certain of the Company's current and former employees and are reflected primarily in other assets, net in the consolidated balance sheets.
Available-for-Sale Marketable Securities
The Company had no available-for-sale securities at December 31, 2018 and 2017. The proceeds from sales and maturities of available-for-sale securities included in the consolidated statements of cash flows and the gross realized gains included in the consolidated statements of operations are reflected in the table below. No gross realized losses were realized during these periods. The cost of securities sold was determined using the specific identification method.
 
 
Year Ended December 31,
 
 
2016
Proceeds from sales and maturities of securities
 
$
663

Gross realized gains
 
54